Friday, September 7, 2012
Jazz Pharma to sell women's health business for $95M
Jazz Pharmaceuticals will sell its women's heath business to specialty pharmaceutical company Meda for $95 million in cash. Jazz, which has an office in Palo Alto (NASDAQ:JAZZ) said in the release that the sale involves six products: Elestrin, Gastrocrom, Natelle One, AVC, Gesticare DHA and Urelle.
Subscribe to:
Post Comments (Atom)
woh I am thankful to find this website through google. great post to read
ReplyDeletePretty good post. I just stumbled upon your blog and wanted to say that I have really enjoyed reading your blog posts. Any way I'll be subscribing to your feed and I hope you post again soon. Big thanks for the useful info. investment management company
ReplyDeleteA very awesome blog post. We are really grateful for your blog post. You will find a lot of approaches after visiting your post. investment management company
ReplyDelete